Introduction
Devel oping countries such as India are currently facing an epidemic of noncommunicable diseases that threaten the lives of millions of people, 1 and unfortunately, they are the very ones that lack resources and robust health care infrastructure. 2 According to the International Diabetes Federation Diabetes Atlas, India already has over 50 million people with diabetes. This number is expected to increase to 87 million by the year 2030. 3 As diabetes is a chronic illness, it requires coordinated medical care and patient self-management to decrease the risk of long-term complications. 4 Modern methods to improve diabetes care include decision support for physicians and/or patients. 5 The various types of electronic health information system include electronic medical records (EMRs), disease registries, personal health records, and administrative data. The EMR system is defined as "the computerization of health record content and associated processes usually referring to an electronic medical health record in a physician office setting or a computerized system of files in a hospital." 6 Several studies have employed advanced health information technologies and clinical decision support systems using functions enabled by EMR systems. [7] [8] [9] There has been a growing recognition of the role of EMR systems in the provision of diabetes care and as an effective management tool to improve diabetes care. [9] [10] [11] It is believed that implementation of EMR systems will lead to health care savings, reduced medical errors, improved implementation of care guidelines, and provision of data for decision support to improve the health of individuals with diabetes. 12, 13 However, there has been little progress toward attaining these goals in developing countries.
Indeed, even in developed nations, the development of EMR systems is still a challenge, as it requires appropriate technologies and adequate resources.
14 This article will first review the use of EMRs in diabetes care in general and then specifically deal with the experience with the diabetes electronic medical record (DEMR) system at our chain of diabetes centers in Chennai (formerly Madras) in Southern India.
Electronic Medical Records in Diabetes Care
Several studies have shown that the quality of care provided for diabetes in most clinics is far from adequate. 15, 16 It is also suggested that well-formulated health care strategies can improve the process of care and outcomes for people with diabetes. 17 Outpatient EMR systems are able to improve the documentation of care, communication of clinical information across sites, and measurement of productivity and variations in the care provided. 18 Inpatient EMR systems have led to improvements in care in some critical clinical domains. 19 Electronic medical records are helpful in adhering to recommendations for proper diabetes management where regular assessment of glycemia, blood pressure, lipid levels, and foot and eye care are essential. 20 Weber and colleagues 11 have shown that diabetes care improved significantly in response to a multifaceted intervention featuring the use of an EMR-derived registry in an integrated delivery system. Some studies have documented improved diabetes-related patient outcomes after EMR implementation, 8, [21] [22] [23] whereas others have shown improvements only in the processes of diabetes care. 23, 24 In controlled studies, EMR systems have had limited positive impact on outpatient diabetes care, and data on improvement of outcomes has been inconsistent. 7, 24, 25 The potential factors/reasons for improvements in diabetes care with EMR use were prompts to physicians identifying when tests [glycated hemoglobin (HbA1c), lipids, microalbuminuria, foot, and retinal examinations] were due and as a reminder of evidence-based goals. 23, 26 Electronic medical records are "enabling technology," although they are neither easy to implement nor inexpensive. 27 Some studies have shown that a computergenerated clinical data set is a support tool as valuable as the stethoscope, provided data entry is done properly. 28, 29 A study in Oman, evaluating physician satisfaction with the EMR system, identified a positive impact in areas of communication, data entry and retrieval, patient care, and reduction of medical errors and some negative aspects, including loss of confidentiality of information and software-related problems. 30 Currently, only a few diabetes centers worldwide have electronic databases, and where available, they are neither optimally utilized nor written in same language (software). Hence, global linking of EMRs has been a great challenge.
Clinical and Research Applications of Diabetes Electronic Medical Records
The DEMR system can improve the organization as well as the efficiency of diabetes health care delivery. As treatment of diabetes is multifaceted, there is a need to take into account many clinical variables when making therapeutic decisions. The DEMR system is increasingly gaining acceptance as an enabling technology that allows physicians to practice evidence-based medicine. 31 With increasing duration of follow-up, patient notes become voluminous, and the accuracy of the information recorded in paper-based medical records becomes difficult to verify and analyze. It is here that the application of EMRs in the management of diabetes becomes very useful as it captures, organizes, analyzes, and helps monitor outcome measures in diabetes care. Through the DEMR, a "patient-centered" approach of providing care is feasible, having the potential for including patient preferences in clinical decision making. Diabetes electronic medical records are undoubtedly valuable resources in conducting medical research. 32, 33 This is also illustrated in our own examples of research applications shown later in this article. However, the confidentiality of patient data should be ensured to be secure and protected. 34 
Barriers to Diabetes Electronic Medical Records
Despite the benefits of EMR systems, adoption of the technology has been slow. 35 In a study conducted in the United States, the most commonly cited barriers to use of EMR systems in hospitals were inadequate capital for purchase (74%), maintenance costs (44%), resistance on the part of physicians (36%), unclear return on investment (32%), and lack of availability of trained staff (30%). Hospitals that had adopted EMR systems were less likely to cite four of these five concerns (all except physicians' resistance) as major barriers to adoption than were hospitals that had not adopted such systems. 36 Other barriers include difficulties in incorporating data from older paper-based records into the electronic system, issues about long-term preservation and storage of data, software problems such as codification and customization, hardware limitations (interfacing with older technology), and issues of security and confidentiality. However, one of the major factors is the reluctance of doctors to use electronic systems. Computerization of health care information was planned at DMDSC even at the time of its inception in 1991. The DMDSC started with stand-alone computers, then moved to computers linked to a local area network system, and finally moved to an online totally computerized system. The online project commenced in late 1996 in collaboration with Novo Nordisk, Denmark. The DMDSC center provided the technical know-how, while CG Maersk Information Technologies developed the software. The project was funded through a generous grant from the Danish Government Private Sector Programme, and the software was initially owned by Novo Nordisk.
Diabetes Electronic Medical Records
The DEMR was designed based on the existing paper medical records at the time but was made more manageable, maintainable, upgradable, retrievable, and user-friendly. The program was designed with Power Builder as the frontend database and structured query language (SQL) server as the backend database. In 2000, the entire DEMR was redesigned and upgraded with the inclusion of billing and in-hospital functions, and DMDSC assumed ownership of the software. Currently, the frontend of the DEMR is designed with Visual Basic and the backend database with SQL server. The present software is more user-friendly, and more functions and modules are continuously being added. Currently, 320 computers across all centers of DMDSC are linked to the DEMR system. All centers are interlinked with leased lines, and there are several servers to support all these activities. Data entries made in various departments are randomly checked at the end of the day for completeness and accuracy of data at the respective centers. Each center has a Microsoft SQL server that is connected to our main server where data are extracted by the Microsoft SQL analyzer. This method is simple and less time consuming, and data are extracted in forms of tables.
The databases are backed up internally and stored automatically in the hard disk every day on the Microsoft SQL server using a scheduler in the server. In addition, periodical tape backups are made and sent for off-site storage at regular intervals. The initial cost to install and set up this DEMR system in India is over 90,000 U.S dollars, and the annual cost to operate it (i.e., run, time spent on data entry, extraction, maintenance, time to educate the users) would be approximately 50,000 U.S. dollars.
Various Modules in Diabetes Electronic Medical Records
The modules in our DEMR system include registration, medical and personal history/anthropometry, test advice, diet advice, physical examination, billing, laboratory, special tests, and in-patient as shown in Figure 1 . Our preliminary experience with DEMRs has been published previously. 37 By providing a unique medical registration number to patients, the DEMR helps us reduce one of the most common, but preventable, medical errors that arises due to wrong identity of the patient. Figures 2 and 3 show two of the illustrative screens viewable by our consultants in the DEMR module. It can be observed that the diabetes control (HbA1c) and status of lipid control during the past visits can be viewed in graphical manner, which makes clinical decision making easier.
In addition, for security and audit trail, a unique user identification and password is given to each individual who uses the DEMR. The user of one department cannot view the modules of another department unless authorized. This helps protect patients' confidentiality.
Clinical and Research Applications: The Dr. Mohan's Diabetes Specialities Centre DEMR Model

Population Characteristics
Clinical
The DMDSC DEMR provides patient-specific assessments and helps clinicians make clinical decisions by flagging the patients who are at high risk for complications, have drug allergies, and need preventive care. By effectively managing a patient's demographics, medical history, medications, test results, diet advice, and physical activity, the DEMR plays a crucial role in providing comprehensive diabetes care.
Of the 226,228 patients registered at our center, 188,030 had different types of diabetes and glucose intolerance. Table 1 provides the breakdown of various types of diabetes and glucose intolerance. 38 It shows that 92.6% of the patients had type 2 diabetes mellitus (T2DM), 1.4% had type 1 diabetes mellitus (T1DM), 0.5% had gestational diabetes, 0.4% had fibrocalculous pancreatic diabetes, 0.2% had maturity onset diabetes of young, 0.3% had impaired fasting glucose, 3.9% had impaired glucose tolerance, and 0.7% comprised other types.
The DEMR helps assess the quality of diabetes care by measuring adherence to guidelines for complications screening in patients with diabetes. 
Research
The DEMR serves as a rich database for answering research questions. Using the DEMR database of DMDSC, several retrospective, cross-sectional, and follow-up studies have been published. [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] Some of these are briefly reviewed here. Studies have been performed to determine the prevalence of, and risk factors for, diabetic retinopathy (DR), 40 proteinuria, 41 microalbuminuria, 42 and neuropathy. 43 Premalatha and associates 44 compared the specificity and sensitivity of ankle-brachial index (ABI) measured by peripheral Doppler with the color duplex ultrasound for diagnosis of peripheral vascular disease (PVD). The sensitivity and specificity of ABI in this study was 70.6 % and 88.5%, respectively. Deepa and coworkers 46 studied 725 T2DM patients with and without diabetic complications to determine the relation of lipoprotein(a) with microvascular and macrovascular complications. The study concluded that lipoprotein(a) were higher in those with coronary artery disease (CAD) and proteinuria but not associated with retinopathy or PVD in our T2DM patients.
A retrospective study conducted by Rema and colleagues 48 in 5000 T2DM patients who underwent a retinal examination between 1995 and 1999 at DMDSC reported that, of the 261 eyes of 160 patients who underwent panretinal photocoagulation, 73% of 191 eyes with good visual acuity (6/9) at baseline maintained the same vision at 1-year follow-up. Of the 53 eyes with visual acuity of 6/12-6/36 at baseline, 58.5% maintained same vision and 18.9% improved their vision at follow-up. Of the 17 eyes with visual acuity ≤6/60 at baseline, 12 maintained the same vision and the remaining 5 improved their vision. This is an example of how DEMR helps to assess outcomes in diabetes patients.
The analysis reported in this section includes a total of 226,228 patients registered in the DEMR system at DMDSC between the years 1991 and 2010. All statistical analyses were performed using SAS statistical package (version 9.0; SAS Institute, Inc., Cary, NC). Numbers are expressed as mean ± standard deviation. Student's t test was used to compare groups for continuous variables. Chi square test was used to compare proportions among groups. For all statistical tests, p value < .05 was considered as the level of significance. .6 mg/dl, p < .001), serum high-density lipoprotein cholesterol (44.9 ± 10.5 vs 39.8 ± 9.3 mg/dl, p < .001), and serum low-density lipoprotein cholesterol (117.6 ± 36.7 vs 111.9 ± 35.7 mg/dl, p < .001), body mass index (BMI; 26.6 ± 4.5 vs 25.1 ± 3.6, p < .001) compared with male patients. Figure 4 shows the percentage distribution of age at diagnosis of T1DM and T2DM patients (for known diabetes patients, it is obtained through the patient's history, while for newly diagnosed diabetes patients, it is the respective age at which they are diagnosed at DMDSC). It can be seen that, while frequency of T1DM is higher (as expected) at lower ages, it is still seen in older age groups. The converse is true for T2DM, where the peak age at onset in our patients occurs between 40 and 49 years of age. Figure 5 shows the grades of obesity among T2DM patients during the first and last visit to DMDSC, the average follow-up visits being 5.0 ± 8.25. Grades of obesity were defined using the World Health Organization Asia Pacific guidelines for Asian Indians. 49 The prevalence of severe obesity (BMI ≥ 30 kg/m The prevalence of various microvascular and macrovascular complications of diabetes at the first visit to this center was also analyzed. The criteria for diagnosis of DR was the presence of microaneurysms in any field photographed in either eye. 50 Neuropathy was diagnosed if the vibratory perception threshold of the right great toe measured by biothesiometry was ≥20. 51 Microalbuminuria was diagnosed if the albumin excretion was between 30 and 299 mg/mg of creatinine. 42 Peripheral vascular disease was diagnosed if ABI < 0.9, 52 and CAD was diagnosed based on a past history of documented myocardial infarction and/or electrocardiographic evidence of Q wave and/or ST segment changes.
53 Table 4 shows that, compared with T1DM patients, T2DM patients had higher prevalence rates of neuropathy, microalbuminuria, CAD, and PVD, while prevalence of DR was similar in both T1DM and T2DM patients.
The prevalence of diabetic complications in relation to duration of diabetes is presented in Table 5 . There was a significant increase in the prevalence of diabetic complications with increase in duration of diabetes: 21.5% of the patients with duration of diabetes <5 years had neuropathy, which increased to 68.9% in those with ≥20 years of duration (p for trend < .001). Similarly, 21.0% of patients with duration of diabetes <5 years had DR, which increased to 70.7% in those with ≥20 years of duration (p for trend < .001). With respect to microalbuminuria, the prevalence increased from 21.0% to 37.7% when the duration of diabetes increased from <5 years to ≥20 years (p for trend < .001). Macrovascular complications, both CAD and PVD, also increased with increasing diabetes duration (p for trend < .001). Figure 6 shows the prevalence of diabetic complications computed in relation to HbA1c levels (using HbA1c levels assessed during their first visit). The prevalence of all complications increased while HbA1c levels increased (p for trend < .001).
Potential Advantages and Disadvantages of the Dr. Mohan's Diabetes Specialities Centre Diabetes Electronic Medical Records System
The factors that influenced the successful implementation and acceptance of a DEMR system at DMDSC included intensive training of all users to bring them to an appropriate level of familiarity with the DEMR system software, an efficient information technology team with a DEMR problem solver, and baseline levels of computer knowledge among the users. Based on the lessons learned with the use of DEMR at our center, the advantages and disadvantages of the DEMR are summarized in Table 6 .
Conclusions
The DEMR is a valuable tool for both clinical and research applications. The DEMR system has helped DMDSC standardize various procedures and has enhanced the quality assurance program, leading to the center's ISO 9001:2008 certification and the laboratory's accreditation by the National Accreditation Board for Testing and Calibration Laboratories and College of American Pathologists. We have shown some of the potential benefits of the DEMR system in the current diabetes care system. A strategy focused on financial support, multiple networking, and training of technical support staff may be necessary to promote broader adoption of the DEMR system by medical service providers in India and other developing countries. 
